MAPK14 and colorectal carcinoma: Moreover, we previously showed that 5-FU and oxaliplatin induce p38 phosphorylation in HCT116 cells and that p38 phosphorylation level is linked to impaired response to FOLFIRI therapy in patients with CRC [33].